At a glance
ClinicalIndex Comparison Record- ✓Confirmed diagnosis of Multiple Sclerosis
- ✓Age 30-60 years
- ✓Moderate disability defined as Patient Determined Disease Steps (PDDS) score 2-6
- ✕Relapse within the last 60 days
- ✕High risk for cardiovascular disease per American College of Sports Medicine risk classification
- ✕Changes in disease-modifying medications within the last 45 days
- ✕Concurrent neurological or neuromuscular disease
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study
In Brief
An observational study evaluating Medical Marijuana for Multiple Sclerosis. Completed, enrolled 22 participants across 1 site.
Detailed Summary
Medical marijuana is commonly prescribed people with Multiple Sclerosis (MS) for symptom, e.g. spasticity and pain, management. Unfortunately not much is known about its effects outside the treatment for these 2 symptoms. Several previous studies have suggested people with MS using medical marijuana have lower levels of physical disability and improved walking abilities. A major limitation of these previous studies is that the investigators used subjective measures of motor function. In this proposed observational case-control study the investigators plan to objectively measure multiple domains of motor function, such as: fatigue, strength, and walking ability. No marijuana will be brought on to campus or given to participants.
Study Details
Timeline
Interventions
To investigate the effects of medical marijuana usage on physical function we will employ an observational case-control design